Paper36968348
Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.
Zhong P and 5 others. Clin Case Rep, 2023. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. Papers, record 36968348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36968348 | Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. | Clin Case Rep | 2023 | https://conductscience.org/library/papers/36968348 | PubMed |
| 2 | 31960755 | Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/31960755 | PubMed |
| 3 | 28485549 | Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia. | Eur J Heart Fail | 2017 | https://conductscience.org/library/papers/28485549 | PubMed |
| 4 | 27806233 | Fulminant Myocarditis with Combination Immune Checkpoint Blockade. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27806233 | PubMed |
| 5 | 28529185 | CARE guidelines for case reports: explanation and elaboration document. | J Clin Epidemiol | 2017 | https://conductscience.org/library/papers/28529185 | PubMed |
| 6 | 32158597 | Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors. | Immune Netw | 2020 | https://conductscience.org/library/papers/32158597 | PubMed |
| 7 | 11209085 | Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. | Science | 2001 | https://conductscience.org/library/papers/11209085 | PubMed |
| 8 | 29567210 | Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. | J Am Coll Cardiol | 2018 | https://conductscience.org/library/papers/29567210 | PubMed |
| 9 | 32765397 | Immune Checkpoint Inhibitor-Induced Myasthenia Gravis. | Front Neurol | 2020 | https://conductscience.org/library/papers/32765397 | PubMed |
| 10 | 28666240 | Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors. | Eur J Cancer | 2017 | https://conductscience.org/library/papers/28666240 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42826309 | Literature review of myasthenia gravis complicated by myocardial damage. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42826309 | PubMed |
| 41789342 | Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/41789342 | PubMed |
| 41188194 | Myocarditis and Myasthenia Gravis Induced by Camrelizumab in a Patient With Metastatic B2 Thymoma: A Case Report. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/41188194 | PubMed |
| 40519300 | Immune-related myocarditis characterized by malignant arrhythmia caused by conduction system involvement: case report and literature review. | Front Oncol | 2025 | https://conductscience.org/library/papers/40519300 | PubMed |
| 40178703 | Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis. | Curr Cardiol Rep | 2025 | https://conductscience.org/library/papers/40178703 | PubMed |
| 39301255 | Myasthenia gravis and myocarditis induced by chemoimmunotherapy in locally advanced gastric cancer: A case report. | Exp Ther Med | 2024 | https://conductscience.org/library/papers/39301255 | PubMed |
| 39263485 | Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review. | Cardiovasc Diagn Ther | 2024 | https://conductscience.org/library/papers/39263485 | PubMed |
| 36968348 | Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. | Clin Case Rep | 2023 | https://conductscience.org/library/papers/36968348 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36968348
GET https://conductscience.org/api/papers/v1/36968348/authors